Get startedLog in
    Picture of Mersana Therapeutics logo

    MRSN — Mersana Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Mersana Therapeutics Q2 EPS USD -0.2

    Picture of Mersana Therapeutics logoMersana Therapeutics
    13/08/2024 12:00
    Aug 13 (Reuters) - Mersana Therapeutics Q2 collaboration revenue USD 2.293
million.
* Q2 net income USD -24.268 million

    Recent news on Mersana Therapeutics

    See all news